Nucleus Radiopharma Inc. is a contract development and manufacturing organization building clinical and commercial supply chains for radiopharmaceuticals, with operations based in locations such as Rochester, Minnesota and North Carolina.
Subscribe to see Nucleus Radiopharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nucleus Radiopharma, Inc. is a healthcare company headquartered in United States. It has raised at least $72.1M across the 3 funding rounds on record, 2 of them with a disclosed amount. Its most recent funding round closed in October 2024. Xcout tracks 7 named people at Nucleus Radiopharma, Inc., including Charles S. Conroy (CEO).
1 more named person on record for Nucleus Radiopharma, Inc., with roles, board committees and tenure — see the full roster →
At least $72.1M raised across the 3 rounds on record (2 with a disclosed amount). Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | Undisclosed | 1 named | |
| Series A Extension | $66.1M | 5 named | |
| SEC Form D filing | $6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Nucleus Radiopharma, Inc.'s closest competitors — see the full list of competitors and alternatives →
AtomVie Global Radiopharma Inc. is a radiopharmaceutical company headquartered in Hamilton, Ontario, Canada. It operates in the pharmaceutical industry, providing specialized products and services related to global radiopharmaceuticals.
August Bioservices, LLC is a contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceuticals. Headquartered in Nashville, Tennessee, the company provides end-to-end clinical and commercial manufacturing services.
Cellipont Bioservices is a cell therapy contract development and manufacturing organization (CDMO) that provides production services for innovative cellular medicines. Headquartered in Texas, the company operates advanced cGMP manufacturing facilities designed to bridge the gap between biomedical innovation and clinical supply. They partner with biotechnology firms to support the development and scaling of complex cell therapies.
KBI Biopharma Inc. is a global contract development and manufacturing organization (CDMO) headquartered in Durham, North Carolina. The company specializes in cell line development, analytical testing, and process manufacturing services for biopharmaceutical clients worldwide.
Aldevron is a life science contract development and manufacturing organization headquartered in Fargo, North Dakota, specializing in plasmid DNA, proteins, and mRNA production for research and clinical applications.
Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.